T lymphocytes expressing the switchable chimeric Fc receptor CD64 exhibit augmented persistence and antitumor activity.
Cui Y, Yuan T, Wang Y, Zheng D, Qin L, Li S, Jiang Z, Lin S, Guo W, Wang Z, Liang Z, Li Y, Yao Y, Liu X, Tang Q, Tu HY, Zhang XC, Tang Z, Wong N, Zhang Z, Qin D, Thiery JP, Xu K, Li P.
Cui Y, et al. Among authors: liang z.
Cell Rep. 2023 Jul 25;42(7):112797. doi: 10.1016/j.celrep.2023.112797. Epub 2023 Jul 11.
Cell Rep. 2023.
PMID: 37436890
Free article.